This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zyss, D. Articles by Coopman, P. J. Search for Related Content PubMed PubMed Citation Articles by Zyss, D. Articles by Coopman, P. J.

The Syk Tyrosine Kinase Localizes to the Centrosomes and Negatively Affects Mitotic Progression

¹ Centre National de la Recherche Scientifique UMR5539, Université Montpellier II and ² Centre de Recherches de Biochimie Macromoléculaire, Centre National de la Recherche Scientifique FRE2593, Montpellier, France

Requests for reprints: Peter J. Coopman, Centre National de la Recherche Scientifique UMR5539, Université Montpellier II, CC107, Place Eugène Bataillon, 34095 Montpellier, France. Phone: 33-467-144731; Fax: 33-467-144286; E-mail: coopman{at}univ-montp2.fr.

We showed previously that the spleen tyrosine kinase Syk is expressed by mammary epithelial cells and that it suppresses malignant growth of breast cancer cells. The exact molecular mechanism of its tumor-suppressive activity remains, however, to be identified. Here, we show that Syk colocalizes and copurifies with the centrosomal component -tubulin and exhibits a catalytic activity within the centrosomes. Moreover, its centrosomal localization depends on its intact kinase activity. Centrosomal Syk expression is persistent in interphase but promptly drops during mitosis, obviously resulting from its ubiquitinylation and proteasomal degradation. Conversely, unrestrained exogenous expression of a fluorescently tagged Discosoma sp. red fluorescent protein (DsRed)-Syk chimera engenders abnormal cell division and cell death. Transient DsRed-Syk overexpression triggers an abrupt cell death lacking hallmarks of classic apoptosis but reminiscent of mitotic catastrophe. Surviving stable DsRed-Syk–transfected cells exhibit multipolar mitotic spindles and contain multiple abnormally sized nuclei and supernumerary centrosomes, revealing anomalous cell division. Taken together, these results show that Syk is a novel centrosomal kinase that negatively affects cell division. Its expression is strictly controlled in a spatiotemporal manner, and centrosomal Syk levels need to decline to allow customary progression of mitosis.

This article has been cited by other articles:

				A. R. Farina, A. Tacconelli, L. Cappabianca, G. Cea, S. Panella, A. Chioda, A. Romanelli, C. Pedone, A. Gulino, and A. R. Mackay The Alternative TrkAIII Splice Variant Targets the Centrosome and Promotes Genetic Instability Mol. Cell. Biol., September 1, 2009; 29(17): 4812 - 4830. [Abstract] [Full Text] [PDF]

				P. R. Hagner, K. Mazan-Mamczarz, B. Dai, S. Corl, X. F. Zhao, and R. B. Gartenhaus Alcohol consumption and decreased risk of non-Hodgkin lymphoma: role of mTOR dysfunction Blood, May 28, 2009; 113(22): 5526 - 5535. [Abstract] [Full Text] [PDF]

				O. Bailet, N. Fenouille, P. Abbe, G. Robert, S. Rocchi, N. Gonthier, C. Denoyelle, M. Ticchioni, J.-P. Ortonne, R. Ballotti, et al. Spleen Tyrosine Kinase Functions as a Tumor Suppressor in Melanoma Cells by Inducing Senescence-like Growth Arrest Cancer Res., April 1, 2009; 69(7): 2748 - 2756. [Abstract] [Full Text] [PDF]

				Y. Zhang, H. Oh, R. A. Burton, J. W. Burgner, R. L. Geahlen, and C. B. Post Tyr130 phosphorylation triggers Syk release from antigen receptor by long-distance conformational uncoupling PNAS, August 19, 2008; 105(33): 11760 - 11765. [Abstract] [Full Text] [PDF]

				G. Collin, M. Franco, V. Simon, C. Benistant, and S. Roche The Tom1L1-Clathrin Heavy Chain Complex Regulates Membrane Partitioning of the Tyrosine Kinase Src Required for Mitogenic and Transforming Activities Mol. Cell. Biol., November 1, 2007; 27(21): 7631 - 7640. [Abstract] [Full Text] [PDF]

				V. Muthusamy, S. Duraisamy, C. M. Bradbury, C. Hobbs, D. P. Curley, B. Nelson, and M. Bosenberg Epigenetic Silencing of Novel Tumor Suppressors in Malignant Melanoma Cancer Res., December 1, 2006; 66(23): 11187 - 11193. [Abstract] [Full Text] [PDF]